OTCMKTS:FRFTF TFF Group (FRFTF) Stock Price, News & Analysis C$20.70 0.00 (0.00%) As of 10/3/2025 Add Compare Share Share Stock Analysis Stock AnalysisChartShort InterestBuy This Stock About TFF Group Stock (OTCMKTS:FRFTF) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get TFF Group alerts:Sign Up Key Stats Today's RangeC$20.70▼C$20.7050-Day RangeC$20.70▼C$42.7552-Week RangeC$20.70▼C$42.75VolumeN/AAverage VolumeN/AMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company Overview TFF Group (OTCMKTS:FRFTF) is a clinical-stage specialty pharmaceutical company developing and commercializing medicines based on its proprietary thin-film drug delivery platform. The company’s core technology transforms active pharmaceutical ingredients into solid films that dissolve rapidly in the oral cavity or adhere to mucosal surfaces, enabling precise dosing without water, potential improvements in bioavailability and the opportunity to create novel dosage forms. TFF Group’s platform supports a broad range of molecules, from small-molecule drugs and peptides to vaccines and biologics. Headquartered in Kansas City, Missouri, with research and manufacturing facilities in Europe, TFF Group applies its thin-film technology across multiple therapeutic areas, including central nervous system disorders, hormone replacement therapy, respiratory diseases and vaccines. Its development pipeline includes thin-film formulations of drugs for insomnia, hormone support and respiratory applications. The company also explores collaborations with biopharmaceutical partners to advance late-stage product candidates into clinical trials and eventual commercialization. Founded in 2009, TFF Group has evolved from an early-stage drug delivery innovator into a diversified R&D organization. The company conducts Phase 1 and Phase 2 clinical studies in the United States and Europe, leveraging strategic partnerships to expand its geographic reach. TFF Group is led by co-founder and Chief Executive Officer Jason E. Sharpe, whose leadership team brings experience in pharmaceutical development, regulatory affairs and manufacturing scale-up. Through its thin-film platform, TFF Group aims to address unmet medical needs and improve patient convenience and adherence worldwide.AI Generated. May Contain Errors. Read More Receive FRFTF Stock News and Ratings via Email Sign-up to receive the latest news and ratings for TFF Group and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. FRFTF Stock News HeadlinesKepler Capital Reaffirms Their Buy Rating on TFF Group (TFF)March 17, 2025 | markets.businessinsider.comTFF Group Reports Revenue Decline Amid Market ChallengesMarch 12, 2025 | tipranks.comAn $8 trillion-dollar discovery 17,000 ft underwater A strange rock pulled from the ocean floor may hold the key to a $16 trillion resource boom. Inside it: materials critical for AI chips, EV batteries, smartphones, and advanced weapons systems. While few people know about these metals, global powers—including the U.S., China, and Russia—are racing to secure them. And one tiny public company, recently backed by the U.S. government, holds mining rights to over 340 million tons… and near-monopoly access to the richest zone.October 4 at 2:00 AM | Porter & Company (Ad)TFF Group Announces 2024/2025 Semester Financial ReportJanuary 28, 2025 | tipranks.comTFF Group (TFF) Receives a Buy from Kepler CapitalJanuary 11, 2025 | markets.businessinsider.comTonnellerie Francois Freres Reports Stable Liquidity Contract ActivityJanuary 9, 2025 | tipranks.comTFF Group Faces Challenging First Semester Amid Market SlowdownJanuary 8, 2025 | tipranks.comTFF Group S.A. (FR0013295789.SG) stock forecast and price targetDecember 29, 2024 | finance.yahoo.comSee More Headlines FRFTF Stock Analysis - Frequently Asked Questions How have FRFTF shares performed this year? TFF Group's stock was trading at C$42.75 at the start of the year. Since then, FRFTF shares have decreased by 51.6% and is now trading at C$20.70. How do I buy shares of TFF Group? Shares of FRFTF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Industry, Sector and Symbol Stock ExchangeOTCMKTS SectorConsumer Cyclical Industry Packaging & Containers Sub-IndustryN/A Current SymbolOTCMKTS:FRFTF CIKN/A Webwww.tff-group.com Phone33 3 80 21 23 33FaxN/AEmployees1,676Year Founded1910Profitability EPS (Trailing Twelve Months)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A (Almost) Everything You Need To Know About The EV MarketLooking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.Get This Free Report This page (OTCMKTS:FRFTF) was last updated on 10/4/2025 by MarketBeat.com Staff From Our PartnersNvidia CEO Makes First Ever Tesla AnnouncementWhile headlines focus on Tesla’s car sales, tech analyst Jeff Brown says the real story is Tesla’s role in a $...Brownstone Research | SponsoredURGENT: The Market's 3 Red Flags Are FlashingThe warning signs that preceded the 2008 crash are reappearing: an irrational NASDAQ bubble, a record-high gol...StockEarnings | SponsoredStunning new initiative unfolding in the White House?what I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | Sponsored$3,600 gold is nice ... but here’s what most gold bugs are missingGold just surged past $3,600, but Weiss Ratings expert Sean Brodrick says the real upside is in select gold st...Weiss Ratings | SponsoredLost Decade warning – do this nowWith the Magnificent 7 trading at bubble-like valuations, another “Lost Decade” could be looming — but Porter ...Porter & Company | SponsoredThe next biggest bull run in over 50 yearsGold has shattered records, soaring past $3,800 an ounce... But Stansberry Senior Partner Dr. David "Doc" E...Stansberry Research | SponsoredArizona-made nanochips the new millionaire maker?George Gilder handed President Reagan the first microchip that helped create $6.5 trillion in wealth over the ...Banyan Hill Publishing | SponsoredMagnificent 7 being replaced by the “Hidden 7”?BULLISH: It's time to buy this 'hidden' AI stock An award-winning stock-rating system has turned BULLISH on...Chaikin Analytics | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding TFF Group Please log in to your account or sign up in order to add this asset to your watchlist. Share TFF Group With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.